Across its top 20 institutional holders, ORA's holder base skews toward low-concentration, low-turnover investors on average (avg. concentration score 8/100, avg. turnover score 23/100).

Quarterly Activity

Recent Activity

+$4.0B

Total Buy Value

$1.9B

Total Sell Value

New buy70

Trim120

Add146

Sold out55

216

Net Buyers

175

Net Sellers

Smart Money Convergence

ORA does not currently have enough recent insider (Form 4) trading activity to compute a convergence signal against its 13F institutional flows.

13F data as of 2026-06-30 quarterly filings. Note: many large institutions file close to the 45-day post-quarter deadline, so early-quarter flow figures can shift substantially as more filings arrive.

Insider Trading (Form 4)

Form 144 Pre-Sale Notices

No Form 144 planned sale filings in the last 90 days

Beneficial Ownership (13D/13G)

No Schedule 13D/13G filings for this ticker

Material Events (8-K)

No Form 8-K filings for this ticker

CUSIP

686688102

FAQ

Who are the top institutional investors holding ORMAT TECHNOLOGIES INC (ORA)?

Major stakeholders currently include BlackRock, Inc. ($1.1B), Vanguard Portfolio Management LLC ($335.6M), UBS Group AG ($309.9M). Based on the latest 13F filings, there are a total of 415 tracked investment funds and institutions maintaining positions in ORA.

What is the overall institutional sentiment toward ORA recently?

Institutional sentiment appears Bullish (Net Buying). During the most recent reporting quarter, the stock experienced a net inflow of $116.1M, driven by 216 managers accumulating shares while 175 reduced their exposure.

Which institutions have been selling or reducing their ORA positions?

In the latest period, 120 funds trimmed their holdings, and 55 managers completely exited their positions. The aggregate reported sell value was $1.9B.

Are there any notable investors adding ORA to their portfolios?

Yes, buying activity remains notable. 70 institutions opened new positions in {ticker}, and 146 existing holders added to their shares. The total reported buy value for the quarter amounted to $4.0B.